Popularized by the $4 Wal-mart and Target plans. Good news for patients. Bad news for Big Pharma.
The booming generic medication business
More in Uncategorized
Past Week
-
Medicine is not apolitical: Your vote dictates your ability to practice medicine
-
Talk to your patients about money
-
Navigating organizational dysfunction: lessons from Boeing
-
Too many older adults are taking risky sedative medications
-
Post-delivery complications: a glimpse into obstetric care
-
EMRs and insurance: a pediatrician’s success story
-
Past 6 Months
-
Do they care if women die? Exploring women’s rights.
-
Medicine is not apolitical: Your vote dictates your ability to practice medicine
-
The abuser’s playbook: the weaponization of mental health
-
Real pain deserves real treatment
-
Health care informatics and the future of patient care
-
Physician burnout: a surgeon’s story of exhaustion, recovery, and systemic change
-
Recent Posts
-
Post-delivery complications: a glimpse into obstetric care
-
Elite access vs. public scrutiny: Medication disparities exposed
-
The Supreme Court must consider science, not pseudo-science, in public health rulings
-
Youth are changing perceptions of death: Here’s what they want you to know
-
Navigating the spiritual crisis in modern medicine [PODCAST]
-
How psychiatry fails trauma survivors
-
Subscribe to KevinMD and never miss a story!
Get free updates delivered free to your inbox.
